A phase I/II study of a 72-h continuous infusion of etoposide in advanced soft tissue sarcoma

By Crawley Charles R   Judson Ian R.   Verrill Mark   Hill Catherine   Raynaud Florence I.  

Sarcoma, Vol. 1, Iss. 3-4, 1997-12 ,pp. : 149-154

Informa Healthcare

Access to resources Recommend Favorite

Temozolomide in adult patients with advanced soft tissue sarcoma: a phase II study of the EORTC Soft Tissue and Bone Sarcoma Group

By Woll P.J.   Judson I.   Lee S.M.   Rodenhuis S.   Nielsen O.S.   Buesa J.M.   Lorigan P.C.   Leyvraz S.   Hermans C.   van Glabbeke M.   Verweij J.  

European Journal of Cancer, Vol. 35, Iss. 3, 1999-03 ,pp. : 410-412

Elsevier

Access to resources Recommend Favorite

Gemcitabine in advanced adult soft-tissue sarcomas. A phase II study of the EORTC Soft Tissue and Bone Sarcoma Group

By Svancarova L.   Blay J.Y.   Judson I.R.   van Hoesel Q.G.C.M.   van Oosterom A.T.   le Cesne A.   Keizer H.J.   Hermans C.   van Glabbeke M.   Verweij J.   Hogendoorn P.C.W.   Nielsen O.S.  

European Journal of Cancer, Vol. 38, Iss. 4, 2002-03 ,pp. : 556-559

Elsevier

Access to resources Recommend Favorite

Effect of high-dose ifosfamide in advanced soft tissue sarcomas. A multicentre phase II study of the EORTC Soft Tissue and Bone Sarcoma Group - is it feasible?

By Nielsen O.S.   Judson I.   van Hoesel Q.   le Cesne A.   Keizer H.J.   Blay J.Y.   van Oosterom A.   Radford J.A.   Svancarova L.   Krzemienlecki K.   Hermans C.   van Glabbeke M.   Oosterhuis J.W.   Verweij J.  

European Journal of Cancer, Vol. 36, Iss. 1, 2000-01 ,pp. : 61-67

Elsevier

Access to resources Recommend Favorite

Dose-intensive first-line chemotherapy with epirubicin and continuous infusion ifosfamide in adult patients with advanced soft tissue sarcomas: a phase II study

By Palumbo R.   Neumaier C.   Cosso M.   Bertero G.   Raffo P.   Spadini N.   Valente S.   Villani G.   Pastorino M.   Toma S.  

European Journal of Cancer, Vol. 35, Iss. 1, 1999-01 ,pp. : 66-72

Elsevier

Access to resources Recommend Favorite